Plasma activated hydrogel therapy as a novel treatment for paediatric burns

Plasma activated hydrogel therapy as a novel treatment for paediatric burns

Chief Investigator: Dr Ainslie Derrick-Roberts Funding Amount : $99,946 Recipient: University of South Australia Overview: Paediatric burns are common in children under the age of 5. Treatment of burns is complicated by
Establishing a Sudden Infant Death Syndrome (SIDS) biobank

Establishing a Sudden Infant Death Syndrome (SIDS) biobank

Chief Investigator: Professor Leanne Dibbens Funding Amount : $90,000 Recipient: University of South Australia Overview: Approximately 100 babies die from Sudden Infant Death Syndrome (SIDS) in Australia each year. The cause(s) of
Development of the next-generation antimicrobial dermal matrix for the management of deep burn injury

Development of the next-generation antimicrobial dermal matrix for the management of deep burn injury

Chief Investigator: Dr Zlatko Kopecki Funding Amount : $100,000 Recipient: University of South Australia Overview: Burns are one of the most common injuries suffered by Australians and one of the top three
Testing combined therapies as a powerful tool for controlling paediatric Glioblastoma multiforme invasiveness.

Testing combined therapies as a powerful tool for controlling paediatric Glioblastoma multiforme invasiveness.

Chief Investigator: Dr Sunita Ramesh Funding Amount : $91,816 Recipient: Flinders University Overview: Glioblastoma multiforme (GBM) is a common cause of cancer-related deaths in children. Current treatments focus on disrupting single signalling

The impact of the complement system on fetal brain and retinal development during viral infection.

Chief Investigator: Associate Professor Jillian Carr Funding Amount : $98,679 Recipient: Flinders University Overview: Sometimes, viral infection during pregnancy infects the baby with devastating and permanent effects on the brain and eye.
A new therapy to mature preterm lungs without damaging the brain

A new therapy to mature preterm lungs without damaging the brain

Chief Investigator: Associate Professor Kathryn Gatford Funding Amount : $100,000 Recipient: The University of Adelaide Overview: Antenatal corticosteroids (ACS), such as betamethasone, are standard clinical care for women at risk of preterm
Reversing fetal growth restriction for better pregnancy and infancy health.

Reversing fetal growth restriction for better pregnancy and infancy health.

Chief Investigator: Dr Macarena Gonzalez Funding Amount : $100,000 Recipient: The University of Adelaide Overview: Fetal growth restriction causes 5.4% of perinatal deaths in Australia and a 3-fold increase in offspring chronic
Does the presence of lung infection impact the efficacy of cystic fibrosis airway gene therapy?

Does the presence of lung infection impact the efficacy of cystic fibrosis airway gene therapy?

Chief Investigator: Dr Alexandra McCarron (Early Career Researcher) Funding Amount : $40,060 Recipient: The University of Adelaide Overview: This project will evaluate a novel treatment for cystic fibrosis (CF), a chronic, progressive,
Using Genetic Models to Tackle Epilepsy

Using Genetic Models to Tackle Epilepsy

Chief Investigator: Associate Professor Cheryl Shoubridge Funding Amount : $93,488 Recipient: The University of Adelaide Overview: Developmental and epileptic encephalopathies (DEE) are a severe form of epilepsy which presents in early childhood.